{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:35:28Z","timestamp":1791408928944,"version":"4.3.3"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T00:00:00Z","timestamp":1193097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2007,10,31]]},"DOI":"10.1007\/s00281-007-0094-z","type":"journal-article","created":{"date-parts":[[2007,10,22]],"date-time":"2007-10-22T07:02:31Z","timestamp":1193036551000},"page":"415-426","source":"Crossref","is-referenced-by-count":54,"title":["Minimal change nephropathy and focal segmental glomerulosclerosis"],"prefix":"10.1007","volume":"29","author":[{"given":"Peter W.","family":"Mathieson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,23]]},"reference":[{"key":"94_CR1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1561-5413(09)60059-4","volume":"3","author":"PW Mathieson","year":"2001","unstructured":"Mathieson PW (2001) Role of the podocyte in glomerular injury. Hong Kong J Nephrol 3:51\u201355","journal-title":"Hong Kong J Nephrol"},{"key":"94_CR2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.ki.5002222","volume":"71","author":"RC Wiggins","year":"2007","unstructured":"Wiggins RC (2007) The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71:1205\u20131214","journal-title":"Kidney Int"},{"key":"94_CR3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/adc.56.7.509","volume":"56","author":"SR Meadow","year":"1981","unstructured":"Meadow SR, Sarsfield JK (1981) Steroid-responsive nephrotic syndrome and allergy: clinical studies. Arch Dis Child 56:509\u2013516","journal-title":"Arch Dis Child"},{"key":"94_CR4","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","volume":"69","author":"V Audard","year":"2006","unstructured":"Audard V, Larousserie F, Grimbert P et al (2006) Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: report of 21 cases and review of the literature. Kidney Int 69:2251\u20132260","journal-title":"Kidney Int"},{"issue":"16 suppl","key":"94_CR5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ndt\/16.suppl_6.74","volume":"6","author":"AB Fogo","year":"2001","unstructured":"Fogo AB (2001) Minimal change disease and focal segmental glomerulosclerosis. Nephrol Dial Transplant 6(16 suppl):74\u201376","journal-title":"Nephrol Dial Transplant"},{"key":"94_CR6","first-page":"333","volume":"79","author":"DJ O\u2019Donoghue","year":"1991","unstructured":"O\u2019Donoghue DJ, Lawler W, Hunt LP et al (1991) IgM-associated primary diffuse mesangial proliferative glomerulonephritis: natural history and prognostic indicators. Q J Med 79:333\u2013350","journal-title":"Q J Med"},{"key":"94_CR7","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/ndt\/gfh434","volume":"19","author":"AH Salmon","year":"2004","unstructured":"Salmon AH, Kamel D, Mathieson PW (2004) Recurrence of IgM nephropathy in a renal allograft. Nephrol Dial Transplant 19:2650\u20132652","journal-title":"Nephrol Dial Transplant"},{"key":"94_CR8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ki.1988.129","volume":"33","author":"DB Bernard","year":"1988","unstructured":"Bernard DB (1988) Extrarenal complications of the nephrotic syndrome. Kidney Int 33:1184\u20131202","journal-title":"Kidney Int"},{"key":"94_CR9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0272-6386(12)80994-2","volume":"23","author":"DC Wheeler","year":"1994","unstructured":"Wheeler DC, Bernard DB (1994) Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment. Am J Kidney Dis 23:331\u2013346","journal-title":"Am J Kidney Dis"},{"key":"94_CR10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"ii","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet ii:556\u2013560","journal-title":"Lancet"},{"key":"94_CR11","first-page":"367","volume":"23","author":"V Audard","year":"2002","unstructured":"Audard V, Grimbert P, Valanciut\u00e9 A et al (2002) Recent approaches to the pathogenesis of minimal change nephrotic syndrome. Nephrologie 23:367\u2013369","journal-title":"Nephrologie"},{"issue":"suppl 6","key":"94_CR12","first-page":"V126","volume":"18","author":"PW Mathieson","year":"2003","unstructured":"Mathieson PW (2003) Immune dysregulation in minimal change nephropathy. Nephrol Dial Transpl 18(suppl 6):V126\u2013V129","journal-title":"Nephrol Dial Transpl"},{"key":"94_CR13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0272-6386(03)00801-1","volume":"42","author":"RJ Johnson","year":"2003","unstructured":"Johnson RJ, Hurtado A, Merszei J et al (2003) Hypothesis: dysregulation of immunologic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide. Am J Kidney Dis 42:575\u2013581","journal-title":"Am J Kidney Dis"},{"key":"94_CR14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000052622","volume":"9","author":"RG Parry","year":"2001","unstructured":"Parry RG, Gillespie KM, Mathieson PW (2001) Effects of type 2 cytokines on cultured human glomerular epithelial cells. Exp Nephrol 9:275\u2013283","journal-title":"Exp Nephrol"},{"key":"94_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.V113413","volume":"11","author":"JG Berg Van den","year":"2000","unstructured":"Van den Berg JG, Aten J, Chand MA et al (2000) Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells. J Am Soc Nephrol 11:413\u2013422","journal-title":"J Am Soc Nephrol"},{"key":"94_CR16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.1995.tb03781.x","volume":"102","author":"W Coers","year":"1995","unstructured":"Coers W, Vos JT, van der Meide PH et al (1995) Interferon-gamma (IFN-\u03b3) and IL-4 expressed during mercury-induced membranous nephropathy are toxic for cultured podocytes. Clin Exp Immunol 102:297\u2013307","journal-title":"Clin Exp Immunol"},{"key":"94_CR17","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.4049\/jimmunol.168.12.6244","volume":"168","author":"TB Huber","year":"2002","unstructured":"Huber TB, Reinhardt HC, Exner M et al (2002) Expression of functional CCR and CXCR chemokine receptors in podocytes. J Immunol 168:6244\u20136252","journal-title":"J Immunol"},{"key":"94_CR18","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","volume":"18","author":"KW Lai","year":"2007","unstructured":"Lai KW, Wei CL, Tan LK et al (2007) Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 18:1476\u20131485","journal-title":"J Am Soc Nephrol"},{"key":"94_CR19","doi-asserted-by":"crossref","first-page":"F26","DOI":"10.1152\/ajprenal.0102.2001","volume":"282","author":"JG Berg Van den","year":"2002","unstructured":"Van den Berg JG, Aten J, Annink C et al (2002) Interleukin-4 and interleukin-13 promote basolateral secretion of H+ and cathepsin L by glomerular visceral epithelial cells. Am J Physiol Renal Physiol 282:F26\u2013F33","journal-title":"Am J Physiol Renal Physiol"},{"key":"94_CR20","first-page":"351","volume":"29","author":"WK Gong","year":"2000","unstructured":"Gong WK, Cheung W, Yap HK (2000) Minimal change nephrotic syndrome\u2014a complex genetic disorder. Ann Acad Med Singap 29:351\u2013356","journal-title":"Ann Acad Med Singap"},{"key":"94_CR21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/cs0780391","volume":"78","author":"AG Clark","year":"1990","unstructured":"Clark AG, Vaughan RW, Stephens HA et al (1990) Genes encoding the beta-chains of HLA-DR7 and HLA-DQw2 define major susceptibility determinants for idiopathic nephrotic syndrome. Clin Sci 78:391\u2013397","journal-title":"Clin Sci"},{"key":"94_CR22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ndt\/4.11.923","volume":"4","author":"A Meyrier","year":"1989","unstructured":"Meyrier A (1989) Treatment of glomerular disease with cyclosporin A. Nephrol Dial Transplant 4:923\u2013931","journal-title":"Nephrol Dial Transplant"},{"key":"94_CR23","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00467-006-0228-x","volume":"21","author":"RD Gilbert","year":"2006","unstructured":"Gilbert RD, Hulse E, Rigden S (2006) Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr Nephrol 21:1698\u20131700","journal-title":"Pediatr Nephrol"},{"key":"94_CR24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.ajkd.2006.10.015","volume":"49","author":"H Fran\u00e7ois","year":"2007","unstructured":"Fran\u00e7ois H, Daugas E, Bensman A et al (2007) Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis 49:158\u2013161","journal-title":"Am J Kidney Dis"},{"key":"94_CR25","first-page":"349","volume":"68","author":"K Katoch","year":"1996","unstructured":"Katoch K (1996) Immunotherapy of leprosy. Indian J Lepr 68:349\u2013361","journal-title":"Indian J Lepr"},{"key":"94_CR26","first-page":"95","volume":"95","author":"RS Mutch","year":"1991","unstructured":"Mutch RS, Hutson PR (1991) Levamisole in the adjuvant treatment of colon cancer. Clin Pharm 95:95\u2013109","journal-title":"Clin Pharm"},{"key":"94_CR27","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/0140-6736(91)93257-A","volume":"337","author":"British Association for Pediatric Nephrology","year":"1991","unstructured":"British Association for Pediatric Nephrology (1991) Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 337:1555\u20131557","journal-title":"Lancet"},{"key":"94_CR28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2567.2000.00042.x","volume":"100","author":"CC Szeto","year":"2000","unstructured":"Szeto CC, Gillespie KM, Mathieson PW (2000) Levamisole induces interleukin 18 and shifts Th1\/Th2 balance. Immunology 100:217\u2013224","journal-title":"Immunology"},{"key":"94_CR29","first-page":"110","volume":"70","author":"H Yokoyama","year":"1987","unstructured":"Yokoyama H, Kida H, Abe T et al (1987) Impaired immunoglobulin G production in minimal change nephrotic syndrome in adults. Clin Exp Immunol 70:110\u2013115","journal-title":"Clin Exp Immunol"},{"key":"94_CR30","first-page":"144","volume":"18","author":"JM Heslan","year":"1982","unstructured":"Heslan JM, Lautie JP, Intrator L et al (1982) Impaired IgG synthesis in patients with the nephrotic syndrome. Clin Nephrol 18:144\u2013147","journal-title":"Clin Nephrol"},{"key":"94_CR31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ajcp\/92.1.68","volume":"92","author":"BL Warshaw","year":"1989","unstructured":"Warshaw BL, Check IJ (1989) IgG subclasses in children with nephrotic syndrome. Am J Clin Pathol 92:68\u201372","journal-title":"Am J Clin Pathol"},{"key":"94_CR32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM197507032930103","volume":"293","author":"J Giangiacomo","year":"1975","unstructured":"Giangiacomo J, Cleary TG, Cole BR et al (1975) Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal-change nephrotic syndrome. N Engl J Med 293:8\u201312","journal-title":"N Engl J Med"},{"key":"94_CR33","first-page":"601","volume":"61","author":"H Yokoyama","year":"1985","unstructured":"Yokoyama H, Kida H, Tani Y et al (1985) Immmunodynamics of minimal change nephrotic syndrome in adults T and B lymphocyte subsets and serum immunoglobulin levels. Clin Exp Immunol 61:601\u2013607","journal-title":"Clin Exp Immunol"},{"key":"94_CR34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00447472","volume":"131","author":"H Schulte-Wissermann","year":"1979","unstructured":"Schulte-Wissermann H, Gortz W, Straub E (1979) IgE in patients with glomerulonephritis and minimal change nephrotic syndrome. Eur J Pediatr 131:105\u2013111","journal-title":"Eur J Pediatr"},{"key":"94_CR35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000184981","volume":"49","author":"KH Shu","year":"1988","unstructured":"Shu KH, Lian JD, Yang YF et al (1988) Serum IgE in primary glomerular diseases and its clinical significance. Nephron 49:24\u201328","journal-title":"Nephron"},{"key":"94_CR36","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1378\/chest.97.6.1408","volume":"97","author":"CC Lin","year":"1990","unstructured":"Lin CC, Chen WP (1990) A study of the relationship between childhood nephrotic syndrome and allergic diseases. Chest 97:1408\u20131411","journal-title":"Chest"},{"key":"94_CR37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"TR Mosmann","year":"1989","unstructured":"Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145\u2013173","journal-title":"Annu Rev Immunol"},{"key":"94_CR38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00467-006-0026-5","volume":"21","author":"CE Araya","year":"2006","unstructured":"Araya CE, Wasserfall CH, Brusko TM et al (2006) A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 21:603\u2013610","journal-title":"Pediatr Nephrol"},{"key":"94_CR39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004670050592","volume":"13","author":"BS Cho","year":"1999","unstructured":"Cho BS, Yoon SR, Jang JY et al (1999) Up-regulation of interleukin-4 and CD23\/FcepsilonRII in minimal change nephrotic syndrome. Pediatr Nephrol 13:199\u2013204","journal-title":"Pediatr Nephrol"},{"key":"94_CR40","first-page":"347","volume":"107","author":"J Kang","year":"1994","unstructured":"Kang J, Bai KM, Wang BL et al (1994) Increased production of interleukin 4 in children with simple idiopathic nephrotic syndrome. Chin Med J 107:347\u2013350","journal-title":"Chin Med J"},{"key":"94_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1996.tb32561.x","volume":"796","author":"AB Kay","year":"1996","unstructured":"Kay AB (1996) TH2-type cytokines in asthma. Ann N Y Acad Sci 796:1\u20138","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 2","key":"94_CR42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2222.1995.tb00428.x","volume":"25","author":"LJ Rosenwasser","year":"1995","unstructured":"Rosenwasser LJ, Klemm DJ, Dresback JK et al (1995) Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25(Suppl 2):74\u201378","journal-title":"Clin Exp Allergy"},{"key":"94_CR43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/cs0960665","volume":"96","author":"RG Parry","year":"1999","unstructured":"Parry RG, Gillespie KM, Parnham AP et al (1999) Polymorphisms of interleukin 4 and interleukin 4 receptor in minimal change nephropathy. Clin Sci 96:665\u2013668","journal-title":"Clin Sci"},{"key":"94_CR44","first-page":"1647","volume":"286","author":"KM Gillespie","year":"1999","unstructured":"Gillespie KM, Anderson KL, Mathieson PW (1999) Polymorphism in the IL13 gene promoter. Science 286:1647","journal-title":"Science"},{"key":"94_CR45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF00915067","volume":"2","author":"C Lenarsky","year":"1982","unstructured":"Lenarsky C, Jordan SC, Ladisch S (1982) Plasma inhibition of lymphocyte proliferation in nephrotic syndrome: correlation with hyperlipidemia. J Clin Immunol 2:276\u2013281","journal-title":"J Clin Immunol"},{"key":"94_CR46","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF00862595","volume":"2","author":"CY Lin","year":"1988","unstructured":"Lin CY (1988) Decreased antibody-dependent cellular cytotoxicity in minimal change nephrotic syndrome. Pediatr Nephrol 2:224\u2013228","journal-title":"Pediatr Nephrol"},{"key":"94_CR47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1651-2227.1989.tb10892.x","volume":"78","author":"ME Estevez","year":"1989","unstructured":"Estevez ME, Voyer LE, Craviotto RJ et al (1989) Dysfunction of the monocyte\u2013macrophage system in the idiopathic minimal change nephrotic syndrome. Acta Paediatr Scand 78:87\u201393","journal-title":"Acta Paediatr Scand"},{"key":"94_CR48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0272-6386(97)90485-6","volume":"30","author":"M Haas","year":"1997","unstructured":"Haas M, Meehan SM, Karrison TG et al (1997) Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976\u20131979 and 1995\u20131997. Am J Kidney Dis 30:621\u2013631","journal-title":"Am J Kidney Dis"},{"key":"94_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CNP63001","volume":"63","author":"D Dragovic","year":"2005","unstructured":"Dragovic D, Rosenstock JL, Wahl SJ et al (2005) Increasing incidence of focal segmental glomerulosclerosis and an examination of demographic patterns. Clin Nephrol 63:1\u20137","journal-title":"Clin Nephrol"},{"key":"94_CR50","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0272-6386(04)01081-9","volume":"44","author":"C Kitiyakara","year":"2004","unstructured":"Kitiyakara C, Eggers P, Kopp JB (2004) Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 44:815\u2013825","journal-title":"Am J Kidney Dis"},{"key":"94_CR51","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ki.1994.388","volume":"46","author":"V D\u2019Agati","year":"1994","unstructured":"D\u2019Agati V (1994) The many masks of focal segmental glomerulosclerosis. Kidney Int 46:1223\u20131241","journal-title":"Kidney Int"},{"key":"94_CR52","doi-asserted-by":"crossref","first-page":"c67","DOI":"10.1159\/000101800","volume":"106","author":"TC Lu","year":"2007","unstructured":"Lu TC, He JC, Klotman PE (2007) Podocytes in HIV-associated nephropathy. Nephron Clin Pract 106:c67\u2013c71","journal-title":"Nephron Clin Pract"},{"key":"94_CR53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ncpneph0025","volume":"1","author":"A Meyrier","year":"2005","unstructured":"Meyrier A (2005) Mechanisms of disease: focal segmental glomerulosclerosis. Nature Clin Pract Nephrol 1:44\u201354","journal-title":"Nature Clin Pract Nephrol"},{"key":"94_CR54","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199604043341402","volume":"334","author":"VJ Savin","year":"1996","unstructured":"Savin VJ, Sharma R, Sharma M et al (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878\u2013883","journal-title":"N Engl J Med"},{"key":"94_CR55","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00007890-200202150-00009","volume":"73","author":"M Sharma","year":"2002","unstructured":"Sharma M, Sharma R, Reddy SR et al (2002) Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation 73:366\u2013372","journal-title":"Transplantation"},{"key":"94_CR56","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1046\/j.1523-1755.2000.00434.x","volume":"58","author":"L Berre Le","year":"2000","unstructured":"Le Berre L, Godfrin Y, Lafond-Peyet L et al (2000) Effect of plasma fractions from patients with focal segmental glomerulosclerosis on rat proteinuria. Kidney Int 58:2502\u20132511","journal-title":"Kidney Int"},{"key":"94_CR57","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1681\/ASN.V1092014","volume":"10","author":"VL Esnault","year":"1999","unstructured":"Esnault VL, Besnier D, Testa A et al (1999) Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies. J Am Soc Nephrol 10:2014\u20132017","journal-title":"J Am Soc Nephrol"},{"key":"94_CR58","first-page":"278","volume":"52","author":"S Kondo","year":"1999","unstructured":"Kondo S, Yoshizawa N, Kusumi Y et al (1999) Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF). Clin Nephrol 52:278\u2013284","journal-title":"Clin Nephrol"},{"key":"94_CR59","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/ndt\/gfg013","volume":"18","author":"M Carraro","year":"2003","unstructured":"Carraro M, Zennaro C, Candiano G et al (2003) Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome. Nephrol Dial Transplant 18:689\u2013693","journal-title":"Nephrol Dial Transplant"},{"key":"94_CR60","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1523-1755.2000.00369.x","volume":"58","author":"R Sharma","year":"2000","unstructured":"Sharma R, Sharma M, McCarthy ET et al (2000) Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro. Kidney Int 58:1973\u20131979","journal-title":"Kidney Int"},{"key":"94_CR61","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2004030172","volume":"16","author":"RJ Coward","year":"2005","unstructured":"Coward RJ, Foster RR, Patton D et al (2005a) Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 16:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"94_CR62","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/ndt\/gfh343","volume":"19","author":"M Carraro","year":"2004","unstructured":"Carraro M, Zennaro C, Artero M et al (2004) The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis. Nephrol Dial Transplant 19:1969\u20131975","journal-title":"Nephrol Dial Transplant"},{"key":"94_CR63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1681\/ASN.V122261","volume":"12","author":"J Bariety","year":"2001","unstructured":"Bariety J, Bruneval P, Hill G et al (2001) Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol 12:261\u2013274","journal-title":"J Am Soc Nephrol"},{"key":"94_CR64","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1097-2765(00)80057-X","volume":"1","author":"M Kestila","year":"1998","unstructured":"Kestila M, Lenkkeri U, Mannikko M et al (1998) Positionally cloned gene for a novel glomerular protein\u2013nephrin\u2014is mutated in congenital nephrotic syndrome. Mol Cell 1:575\u2013582","journal-title":"Mol Cell"},{"key":"94_CR65","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0002-9440(10)65483-1","volume":"155","author":"H Holth\u00f6fer","year":"1999","unstructured":"Holth\u00f6fer H, Ahola H, Solin ML et al (1999) Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney. Am J Pathol 155:1681\u20131687","journal-title":"Am J Pathol"},{"key":"94_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/10.1.1","volume":"10","author":"H Putaala","year":"2001","unstructured":"Putaala H, Soininen R, Kilpel\u00e4inen P et al (2001) The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 10:1\u20138","journal-title":"Hum Mol Genet"},{"key":"94_CR67","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/74166","volume":"24","author":"N Boute","year":"2000","unstructured":"Boute N, Gribouval O, Roselli S et al (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349\u2013354","journal-title":"Nat Genet"},{"key":"94_CR68","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1126\/science.286.5438.312","volume":"286","author":"NY Shih","year":"1999","unstructured":"Shih NY, Li J, Karpitskii V et al (1999) Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286:312\u2013315","journal-title":"Science"},{"key":"94_CR69","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0002-9440(10)63080-5","volume":"159","author":"NY Shih","year":"2001","unstructured":"Shih NY, Li J, Cotran R et al (2001) CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol 159:2303\u20132308","journal-title":"Am J Pathol"},{"key":"94_CR70","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/73456","volume":"24","author":"JM Kaplan","year":"2000","unstructured":"Kaplan JM, Kim SH, North KN et al (2000) Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24:251\u2013256","journal-title":"Nat Genet"},{"key":"94_CR71","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1106215","volume":"308","author":"MP Winn","year":"2005","unstructured":"Winn MP, Conlon PJ, Lynn KL et al (2005) A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308:1801\u20131804","journal-title":"Science"},{"key":"94_CR72","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1681\/ASN.2005090962","volume":"17","author":"MP Winn","year":"2006","unstructured":"Winn MP, Daskalakis N, Spurney RF et al (2006) Unexpected role of TRPC6 channel in familial nephrotic syndrome: does it have clinical implications? J Am Soc Nephrol 17:378\u2013387","journal-title":"J Am Soc Nephrol"},{"key":"94_CR73","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1523-1755.1998.00044.x","volume":"54","author":"W Kriz","year":"1998","unstructured":"Kriz W, Gretz N, Lemley K (1998) Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 54:687\u2013697","journal-title":"Kidney Int"},{"key":"94_CR74","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s001250051447","volume":"42","author":"TW Meyer","year":"1999","unstructured":"Meyer TW, Bennett PH, Nelson RG (1999) Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia 42:1341\u20131344","journal-title":"Diabetologia"},{"key":"94_CR75","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1681\/ASN.2004080720","volume":"16","author":"T Matsusaka","year":"2005","unstructured":"Matsusaka T, Xin J, Niwa S et al (2005) Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol 16:1013\u20131023","journal-title":"J Am Soc Nephrol"},{"key":"94_CR76","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1681\/ASN.2005010055","volume":"16","author":"BL Wharram","year":"2005","unstructured":"Wharram BL, Goyal M, Wiggins JE et al (2005) Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16:2941\u20132952","journal-title":"J Am Soc Nephrol"},{"key":"94_CR77","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.gim.0000200947.09626.1c","volume":"8","author":"N Francheschini","year":"2006","unstructured":"Francheschini N, North KE, Kopp JB et al (2006) NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review. Genet Med 8:63\u201375","journal-title":"Genet Med"},{"key":"94_CR78","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1126\/science.1081068","volume":"300","author":"JM Kim","year":"2003","unstructured":"Kim JM, Wu H, Green G et al (2003) CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300:1298\u2013300","journal-title":"Science"},{"key":"94_CR79","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1152\/physiolgenomics.00201.2004","volume":"21","author":"MS Orloff","year":"2005","unstructured":"Orloff MS, Iyengar SK, Winkler CA et al (2005) Variants in the Wilms\u2019 tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics 21:212\u2013221","journal-title":"Physiol Genomics"},{"key":"94_CR80","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1097\/01.ASN.0000039569.34360.5E","volume":"13","author":"MR Pollak","year":"2002","unstructured":"Pollak MR (2002) Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. J Am Soc Nephrol 13:3016\u20133023","journal-title":"J Am Soc Nephrol"},{"key":"94_CR81","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/01.ASN.0000059864.88610.5E","volume":"14","author":"JL Michaud","year":"2003","unstructured":"Michaud JL, Lemieux LI, Dub\u00e9 M et al (2003) Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4. J Am Soc Nephrol 14:1200\u20131211","journal-title":"J Am Soc Nephrol"},{"key":"94_CR82","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1371\/journal.pbio.0020167","volume":"2","author":"J Yao","year":"2004","unstructured":"Yao J, Le TC, Kos CH et al (2004) Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PLoS Biol 2:e167","journal-title":"PLoS Biol"},{"key":"94_CR83","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/ng1592","volume":"37","author":"J Reiser","year":"2005","unstructured":"Reiser J, Polu KR, M\u00f6ller CC et al (2005) TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37:739\u2013744","journal-title":"Nat Genet"},{"key":"94_CR84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1681\/ASN.2006091010","volume":"18","author":"CC M\u00f6ller","year":"2007","unstructured":"M\u00f6ller CC, Wei C, Altintas MM et al (2007) Induction of TRPC6 Channel in Acquired Forms of Proteinuric Kidney Disease. J Am Soc Nephrol 18:29\u201336","journal-title":"J Am Soc Nephrol"},{"key":"94_CR85","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/excr.1997.3739","volume":"236","author":"P Mundel","year":"1997","unstructured":"Mundel P, Reiser J, Zuniga Mejia Borja A et al (1997) Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236:248\u2013258","journal-title":"Exp Cell Res"},{"key":"94_CR86","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","volume":"13","author":"MA Saleem","year":"2002","unstructured":"Saleem MA, O\u2019Hare MJ, Reiser J et al (2002b) A conditionally immortalised human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13:630\u2013638","journal-title":"J Am Soc Nephrol"},{"key":"94_CR87","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0002-9440(10)64421-5","volume":"161","author":"MA Saleem","year":"2002","unstructured":"Saleem MA, Ni L, Witherden I et al (2002a) Co-localization of nephrin, podocin, and the actin cytoskeleton: evidence for a role in podocyte foot process formation. Am J Pathol 161:1459\u20131466","journal-title":"Am J Pathol"},{"key":"94_CR88","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser J, von Gersdorff G, Loos M et al (2004) Induction of B7\u20131 in podocytes is associated with nephrotic syndrome. J Clin Invest 113:1390\u20131397","journal-title":"J Clin Invest"},{"key":"94_CR89","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ki.1997.346","volume":"52","author":"ZI Niemir","year":"1997","unstructured":"Niemir ZI, Stein H, Dworacki G et al (1997) Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides. Kidney Int 52:393\u2013403","journal-title":"Kidney Int"},{"key":"94_CR90","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.ki.5001655","volume":"70","author":"CY Xing","year":"2006","unstructured":"Xing CY, Saleem MA, Coward RJ et al (2006) Direct effects of dexamethasone on human podocytes. Kidney Int 70:1038\u20131045","journal-title":"Kidney Int"},{"key":"94_CR91","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00020.2002","volume":"83","author":"H Pavenstadt","year":"2003","unstructured":"Pavenstadt H, Kriz W, Kretzler M (2003) Cell biology of the glomerular podocyte. Physiology Reviews 83:253\u2013307","journal-title":"Physiology Reviews"},{"key":"94_CR92","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1523-1755.2001.059003923.x","volume":"59","author":"SJ Mudge","year":"2001","unstructured":"Mudge SJ, Paizis K, Auwardt RB et al (2001) Activation of nuclear factor-kappa B by podocytes in the autologous phase of passive Heymann nephritis. Kidney Int 59:923\u2013931","journal-title":"Kidney Int"},{"key":"94_CR93","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.bbrc.2007.06.082","volume":"360","author":"Y Takano","year":"2007","unstructured":"Takano Y, Hiramatsu N, Okamura M et al (2007) Suppression of cytokine response by GATA inhibitor K-7174 via unfolded protein response. Biochem Biophys Res Commun 360:470\u2013475","journal-title":"Biochem Biophys Res Commun"},{"key":"94_CR94","first-page":"348","volume":"79","author":"SH Sacks","year":"1993","unstructured":"Sacks SH, Zhou W, Pani A et al (1993) Complement C3 gene expression and regulation in human glomerular epithelial cells. Immunology 79:348\u2013354","journal-title":"Immunology"},{"key":"94_CR95","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1172\/JCI110529","volume":"69","author":"MD Kazatchkine","year":"1982","unstructured":"Kazatchkine MD, Fearon DT, Appay MD et al (1982) Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases. J Clin Invest 69:900\u2013912","journal-title":"J Clin Invest"},{"key":"94_CR96","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI200315645","volume":"111","author":"JW Pippin","year":"2003","unstructured":"Pippin JW, Durvasula R, Petermann A et al (2003) DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. J Clin Invest 111:877\u2013885","journal-title":"J Clin Invest"},{"key":"94_CR97","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1053\/j.ajkd.2006.07.025","volume":"48","author":"HM Chen","year":"2006","unstructured":"Chen HM, Liu ZH, Zeng CH et al (2006) Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis 48:772\u2013779","journal-title":"Am J Kidney Dis"},{"key":"94_CR98","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.2337\/diabetes.54.11.3095","volume":"54","author":"RJM Coward","year":"2005","unstructured":"Coward RJM, Welsh GI, Yang J et al (2005b) The human glomerular podocyte is a novel target for insulin action. Diabetes 54:3095\u20133102","journal-title":"Diabetes"},{"key":"94_CR99","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2337\/db06-0693","volume":"56","author":"RJ Coward","year":"2007","unstructured":"Coward RJ, Welsh GI, Koziell A et al (2007) Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes 56:1127\u20131135","journal-title":"Diabetes"},{"key":"94_CR100","first-page":"453","volume":"18","author":"CE Mogensen","year":"1980","unstructured":"Mogensen CE, Christensen NJ, Gundersen HJ (1980) The acute effect of insulin on heart rate, blood pressure, plasma noradrenaline and urinary albumin excretion. The role of changes in blood glucose. Diabetologia 18:453\u2013457","journal-title":"Diabetologia"},{"key":"94_CR101","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00402539","volume":"35","author":"J Hilsted","year":"1992","unstructured":"Hilsted J, Christensen NJ (1992) Dual effect of insulin on plasma volume and transcapillary albumin transport. Diabetologia 35:99\u2013103","journal-title":"Diabetologia"},{"key":"94_CR102","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1523-1755.2000.00152.x","volume":"58","author":"L Barisoni","year":"2000","unstructured":"Barisoni L, Bruggeman LA, Mundel P et al (2000) HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 58:173\u2013181","journal-title":"Kidney Int"},{"key":"94_CR103","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1681\/ASN.V1281677","volume":"12","author":"EJ Schwartz","year":"2001","unstructured":"Schwartz EJ, Cara A, Snoeck H et al (2001) Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. J Am Soc Nephrol 12:1677\u20131684","journal-title":"J Am Soc Nephrol"},{"key":"94_CR104","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1681\/ASN.V10151","volume":"10","author":"L Barisoni","year":"1999","unstructured":"Barisoni L, Kriz W, Mundel P et al (1999) The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10:51\u201361","journal-title":"J Am Soc Nephrol"},{"key":"94_CR105","doi-asserted-by":"crossref","first-page":"c67","DOI":"10.1159\/000101800","volume":"106","author":"TC Lu","year":"2007","unstructured":"Lu TC, He JC, Klotman PE (2007) Podocytes in HIV-Associated Nephropathy. Nephron Clin Pract 106:c67\u2013c71","journal-title":"Nephron Clin Pract"},{"key":"94_CR106","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/01.ASN.0000078803.53165.C9","volume":"14","author":"K Koop","year":"2003","unstructured":"Koop K, Eikmans M, Baelde HJ et al (2003) Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 14:2063\u20132071","journal-title":"J Am Soc Nephrol"},{"key":"94_CR107","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00467-003-1346-3","volume":"19","author":"SR Hingorani","year":"2004","unstructured":"Hingorani SR, Finn LS, Kowalewska J et al (2004) Expression of nephrin in acquired forms of nephrotic syndrome in childhood. Pediatr Nephrol 19:300\u2013305","journal-title":"Pediatr Nephrol"},{"key":"94_CR108","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/18.1.70","volume":"18","author":"A Wernerson","year":"2003","unstructured":"Wernerson A, Dun\u00e9r F, Pettersson E et al (2003) Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome. Nephrol Dial Transplant 18:70\u201376","journal-title":"Nephrol Dial Transplant"},{"key":"94_CR109","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000013302","volume":"18","author":"M Hara","year":"1998","unstructured":"Hara M, Yanagihara T, Takada T et al (1998) Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol 18:35\u201341","journal-title":"Am J Nephrol"},{"key":"94_CR110","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000046097","volume":"89","author":"M Hara","year":"2001","unstructured":"Hara M, Yanagihara T, Kihara I (2001) Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 89:342\u2013347","journal-title":"Nephron"},{"key":"94_CR111","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/ndt\/15.9.1379","volume":"15","author":"T Nakamura","year":"2000","unstructured":"Nakamura T, Ushiyama C, Suzuki S (2000) Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 15:1379\u20131383","journal-title":"Nephrol Dial Transplant"},{"key":"94_CR112","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1053\/meta.2001.26703","volume":"50","author":"T Nakamura","year":"2001","unstructured":"Nakamura T, Ushiyama C, Osada S et al (2001) Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. Metabolism 50:1193\u20131196","journal-title":"Metabolism"},{"key":"94_CR113","doi-asserted-by":"crossref","first-page":"c61","DOI":"10.1159\/000101799","volume":"106","author":"A Petermann","year":"2007","unstructured":"Petermann A, Floege J (2007) Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. Nephron Clin Pract 106:c61\u2013c66","journal-title":"Nephron Clin Pract"},{"key":"94_CR114","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.2337\/diabetes.52.12.2969","volume":"52","author":"A P\u00e4t\u00e4ri","year":"2003","unstructured":"P\u00e4t\u00e4ri A, Forsblom C, Havana M et al (2003) Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes 52:2969\u20132974","journal-title":"Diabetes"},{"key":"94_CR115","doi-asserted-by":"crossref","first-page":"c169","DOI":"10.1159\/000104428","volume":"106","author":"G Wang","year":"2007","unstructured":"Wang G, Lai FM, Lai KB et al (2007) Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy. Nephron Clin Pract 106:c169\u2013c179","journal-title":"Nephron Clin Pract"},{"key":"94_CR116","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1111\/j.1523-1755.2005.00723.x","volume":"68","author":"RF Ransom","year":"2005","unstructured":"Ransom RF, Lam NG, Hallett MA et al (2005) Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int 68:2473\u20132483","journal-title":"Kidney Int"},{"key":"94_CR117","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2353\/ajpath.2007.060882","volume":"170","author":"A Gianella","year":"2007","unstructured":"Gianella A, Nobili E, Abbate M et al (2007) Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats. Am J Pathol 170:1165\u20131177","journal-title":"Am J Pathol"},{"key":"94_CR118","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1159\/000100498","volume":"106","author":"L Gu","year":"2007","unstructured":"Gu L, Ni Z, Qian J et al (2007) Pravastatin inhibits carboxymethyllysine-induced monocyte chemoattractant protein 1 expression in podocytes via prevention of signalling events. Nephron Exp Nephrol 106:e1\u2013e10","journal-title":"Nephron Exp Nephrol"},{"key":"94_CR119","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/sj.ki.5002248","volume":"71","author":"T Kanjanabuch","year":"2007","unstructured":"Kanjanabuch T, Ma LJ, Chen J et al (2007) PPAR-gamma agonist protects podocytes from injury. Kidney Int 71:1232\u20131239","journal-title":"Kidney Int"},{"key":"94_CR120","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.ki.5002362","volume":"72","author":"CM Logar","year":"2007","unstructured":"Logar CM, Brinkkoetter PT, Krofft RD et al (2007) Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo. Kidney Int 72:489\u2013498","journal-title":"Kidney Int"},{"key":"94_CR121","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9440(10)63966-1","volume":"158","author":"A Fornoni","year":"2001","unstructured":"Fornoni A, Li H, Foschi A et al (2001) Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis. Am J Pathol 158:275\u2013280","journal-title":"Am J Pathol"},{"key":"94_CR122","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1517\/14656566.6.9.1539","volume":"6","author":"A Meyrier","year":"2005","unstructured":"Meyrier A (2005b) Treatment of focal segmental glomerulosclerosis. Expert Opin Pharmacother 6:1539\u20131549","journal-title":"Expert Opin Pharmacother"},{"key":"94_CR123","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2215\/CJN.03751106","volume":"2","author":"E Letavernier","year":"2007","unstructured":"Letavernier E, Bruneval P, Mandet C et al (2007) High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin J Am Soc Nephrol 2:326\u2013333","journal-title":"Clin J Am Soc Nephrol"},{"key":"94_CR124","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1634\/stemcells.2006-0201","volume":"24","author":"EI Prodromidi","year":"2006","unstructured":"Prodromidi EI, Poulsom R, Jeffery R et al (2006) Bone marrow derived-cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of alport syndrome. Stem Cells 24:2448\u20132455","journal-title":"Stem Cells"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-007-0094-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-007-0094-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-007-0094-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T01:01:05Z","timestamp":1629939665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-007-0094-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,23]]},"references-count":124,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10,31]]}},"alternative-id":["94"],"URL":"https:\/\/doi.org\/10.1007\/s00281-007-0094-z","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,23]]}}}